Clinical Trial Update: Selenium Supplementation in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating selenium supplementation in COPD patients with cardiovascular disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Selenium supplement (selenium)

Snippet

Sponsor: St. Joseph's Health Care London | Conditions: Chronic Obstructive Pulmonary Disease, Cardiovascular Disease | Phase 4 | Status: COMPLETED